Armstrong Ben G, Mangtani Punam, Fletcher Astrid, Kovats Sari, McMichael Anthony, Pattenden Sam, Wilkinson Paul
London School of Hygiene and Tropical Medicine, London WC1E 7HT.
BMJ. 2004 Sep 18;329(7467):660. doi: 10.1136/bmj.38198.594109.AE. Epub 2004 Aug 15.
To estimate the protection against death provided by vaccination against influenza.
Prospective cohort follow up supplemented by weekly national counts of influenza confirmed in the community.
Primary care.
24,535 patients aged over 75 years from 73 general practices in Great Britain.
Death.
In unvaccinated members of the cohort daily all cause mortality was strongly associated with an index of influenza circulating in the population (mortality ratio 1.16, 95% confidence interval 1.04 to 1.29 at 90th centile of circulating influenza). The association was strongest for respiratory deaths but was also present for cardiovascular deaths. In contrast, in vaccinated people mortality from any cause was not associated with circulating influenza. The difference in patterns between vaccinated and unvaccinated people could not easily be due to chance (P = 0.02, all causes).
This study, using a novel and robust approach to control for confounding, provides robust evidence of a protective effect on mortality of vaccination against influenza.
评估流感疫苗接种对死亡的预防作用。
前瞻性队列随访,并辅以每周全国社区确诊流感病例数。
基层医疗。
来自英国73家全科诊所的24535名75岁以上患者。
死亡。
在未接种疫苗的队列成员中,全因每日死亡率与人群中流感传播指数密切相关(在流感传播第90百分位数时,死亡率比值为1.16,95%置信区间为1.04至1.29)。这种关联在呼吸道死亡中最为明显,但在心血管死亡中也存在。相比之下,在接种疫苗的人群中,任何原因导致的死亡率与流感传播无关。接种疫苗和未接种疫苗人群之间的模式差异不太可能是偶然因素造成的(P = 0.02,全因)。
本研究采用新颖且有力的方法控制混杂因素,为流感疫苗接种对死亡率的保护作用提供了有力证据。